Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2018
Home
2018
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appointment and Resignation of Company Secretary
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
EGM Presentation by CEO
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Results of the Extraordinary General Meeting of Members
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid’s Lead Antibody Effective in Rare Chronic Kidney Disease
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 3B
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cleansing Notice
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Director’s Interest Notice_Halasz
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Director’s Interest Notice_Gordon
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Director’s Interest Notice_Eck
Prev page
1
2
3
4
5
6
7
8
Next page
